Search results
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided ...
Regeneron Pharma earnings missed by $0.64, revenue fell short of estimates By Investing.com
Investing.com· 4 days agoRegeneron Pharma earnings missed by $0.64, revenue fell short of estimates
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation - Regeneron...
Benzinga· 3 days agoOn Thursday, Regeneron Pharmaceuticals Inc REGN reported first-quarter adjusted EPS of $9.55, down...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 4 days agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 3 days agoRegeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due to...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 3 days agoRegeneron stock jumped Thursday, bolstered by strong sales of a high-dose version of its blockbuster...
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoRegeneron showcases robust product sales growth amidst competitive pharmaceutical landscape....
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 4 days ago(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 4 days agoResearch and Development: R&D expenses increased by 13% to $1.248 billion, reflecting ongoing...